Ribonucleic acid-based therapy for aging-associated diseases and Lifespan extension: LncRNA CCAT1  inhibits the interaction of DBC1 with PARP1, increases the PARP1 activity, promotes DNA repair, augments tolerance against radiation, cancer, and aging, via down-regulation of its target gene, 3/March/2019, 8.50 am